Intrathecal Bolus Doses of Ziconotide
NCT01373983
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
26
Enrollment
OTHER
Sponsor class
Conditions
Peripheral Neuropathy
Interventions
DRUG:
Ziconotide
Sponsor
University Hospital, Linkoeping